MDMAR
Appearance
(Redirected from 3,4-Methylenedioxy-4-methylaminorex)
Clinical data | |
---|---|
Other names | 3',4'-Methylenedioxy-4-methylaminorex |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C11H12N2O3 |
Molar mass | 220.228 g·mol−1 |
3D model (JSmol) | |
| |
|
3',4'-Methylenedioxy-4-methylaminorex (MDMAR) is a recreational designer drug from the substituted aminorex family, with monoamine-releasing effects.[1][2][3]
See also
[edit]- 2C-B-aminorex
- 4B-MAR
- 4C-MAR
- 4,4'-DMAR
- 4'-Fluoro-4-methylaminorex
- 5-MAPB
- MDMA
- Methylenedioxyphenmetrazine
- List of aminorex analogues
References
[edit]- ^ McLaughlin G, Morris N, Kavanagh PV, Power JD, Twamley B, O'Brien J, et al. (July 2015). "Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR)". Drug Testing and Analysis. 7 (7): 555–64. doi:10.1002/dta.1732. PMC 5331736. PMID 25331619.
- ^ Zawilska JB, Andrzejczak D (December 2015). "Next generation of novel psychoactive substances on the horizon - A complex problem to face". Drug and Alcohol Dependence. 157: 1–17. doi:10.1016/j.drugalcdep.2015.09.030. PMID 26482089.
- ^ Maier J, Mayer FP, Brandt SD, Sitte HH (October 2018). "DARK Classics in Chemical Neuroscience: Aminorex Analogues". ACS Chemical Neuroscience. 9 (10): 2484–2502. doi:10.1021/acschemneuro.8b00415. PMC 6287711. PMID 30269490.